SUBSCRIBE
SUBSCRIBE
News   Business

Bioject Medical Technologies Inc. Q3 Loss Narrows; CEO To Retire

November 2, 2006 | 
1 min read
BIOJECT MEDICAL TECHNOLOGIES INC. (BJCT.O: Quote, Profile, Research) The company, which makes needle-free drug delivery systems, said Chief Executive Jim O'Shea would to retire at year-end. (Reporting by Saumyadeb Chakrabarty in Bangalore)
People
MORE ON THIS TOPIC
Cairo, Egypt, October 31 2024: Novartis CO building in Egypt, Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland, manufactures the drugs
Cardiovascular disease
Novartis Doubles Down on Argo Pact With Fresh $5.2B Commitment
September 3, 2025
 · 
2 min read
 · 
Tristan Manalac
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Novartis Continues Cutting Spree With 58 Sacked in New Jersey
September 3, 2025
 · 
195 min read
 · 
BioSpace Editorial Staff
FDA
Offit Out at FDA Vaccine Advisory Committee After HHS Rebuff
September 2, 2025
 · 
3 min read
 · 
Heather McKenzie
Building a rocket. Halftone hands assemble a rocket shaped puzzle. Concept of a startup, new business. Hasty rocket launch. Innovation, teamwork, development of ideas and technologies
Deals
Vertex, Enlaza Declare War on Autoimmune Disease in Potential $2B+ Pact
September 2, 2025
 · 
2 min read
 · 
Heather McKenzie